[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -X%
6 Months: XX% -X%
1-Year High: XXX% on 2024-11-17
1-Year Low: XX% on 2024-11-21
Most Supportive Themes
- Potential for 180-day extension and Nasdaq compliance: (45%) Community anticipates a 6-month extension from Nasdaq, which could lead to significant price movement.
- Positive Preclinical Data and Partnerships: (35%) Recent preclinical data for ABP-102/CT-P72 (HER2 x CD3) with Celltrion and partnerships are viewed positively.
- Undervaluation and Long-Term Upside: (15%) Many posts highlight the stock's current undervaluation, with some analysts predicting substantial long-term gains.
Most Critical Themes
- Nasdaq Non-Compliance and Dilution Concerns: (5%) The stock's non-compliance with Nasdaq's minimum bid price and concerns about potential dilution are causing some caution.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XX | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XX | X% |